Exai Bio

Palo Alto, United States

Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.

Dec 2021

Series A

Top Investors

S32Two Sigma VenturesCasdin Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Exai Bio's investors?

Exai Bio's investors include S32, Two Sigma Ventures, Casdin Capital.

Where is Exai Bio headquartered?

Exai Bio is headquartered in Palo Alto, United States.

What does Exai Bio do?

Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.

What stage is Exai Bio at?

Exai Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 9, 2021.

MLA

"Exai Bio — Funding & Investors." VCBacked, December 9, 2021, https://www.vcbacked.co/company/exai-bio. Accessed July 1, 2026.

APA

VCBacked. (2021). Exai Bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/exai-bio

Wikipedia (cite web)

{{cite web |title=Exai Bio — Funding & Investors |url=https://www.vcbacked.co/company/exai-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 9, 2021.